Pathway Financial Advisers’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,519
Closed -$203K 165
2025
Q3
$203K Sell
1,519
-15
-1% -$1.97K 0.06% 156
2025
Q2
$209K Buy
+1,534
New +$202K 0.07% 157
2025
Q1
Sell
-1,384
Closed -$1.81M 160
2024
Q4
$1.81M Sell
1,384
-1,381
-50% -$160K 0.61% 55
2024
Q3
$315K Buy
2,765
+1,382
+100% +$152K 0.14% 103
2024
Q2
$144K Buy
1,383
+3
+0.2% +$318 0.05% 168
2024
Q1
$157K Buy
1,380
+1
+0.1% +$115 0.06% 168
2023
Q4
$152K Buy
1,379
+1
+0.1% +$100 0.06% 167
2023
Q3
$133K Buy
+1,378
New +$145K 0.06% 173
2023
Q1
$139K Sell
1,368
-4,177
-75% -$441K 0.06% 173
2022
Q4
$609K Buy
+5,545
New +$574K 0.25% 101

Other funds holding ABT

Pathway Financial Advisers's ABT Position: Q4 2025 in Review

Pathway Financial Advisers sold out of Abbott (ABT) in Q4 2025, closing a stake of 1,519 shares — an estimated $203K sold.

Pathway Financial Advisers first reported a position in ABT in Q4 2022 and held it in 10 quarters. The position peaked at $1.81M in Q4 2024. 3,284 funds tracked by Wall St. Rank hold ABT as of Q4 2025.

  • Pathway Financial Advisers reported no remaining Abbott position as of Q4 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 1,519 Abbott shares in Q4 2025, an estimated $203K.
  • Pathway Financial Advisers first reported a position in Abbott in Q4 2022 and held it in 10 quarters.
  • Pathway Financial Advisers's Abbott position peaked at $1.81M in Q4 2024.
  • 3,284 funds tracked by Wall St. Rank held Abbott as of Q4 2025.

Based on Pathway Financial Advisers's 13F filing for Q4 2025, filed 6 Feb 2026.